Retrovirus-mediated gene transfer targeted to malignant glioma cells in murine brain.

Improved Adeno-associated Viral Gene Transfer to Murine Glioma.

Light-controlled inhibition of malignant glioma by opsin gene transfer.

Gene therapy for malignant glioma.

Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma.

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line.

Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound.

Corrigendum to "CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells".

p16 Gene Transfer Induces Centrosome Amplification and Abnormal Nucleation Associated with Survivin Downregulation in Glioma Cells.

The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.

Gene transfer into murine hematopoietic stem cells and bone marrow stromal cells.

Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy.

Bradykinin enhances invasion of malignant glioma into the brain parenchyma by inducing cells to undergo amoeboid migration.

SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin.

Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.

Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiency.

Nonhuman adenovirus vectors for gene transfer to the brain (BrainCAV).

Vaccine therapies in malignant glioma.

Malignant glioma in laboratory workers.

Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells.

Serial transfer of a human gene to rodent cells by sequential chromosome-mediated gene transfer.

Immunotherapy for malignant glioma.

BCNU and malignant glioma.

Aptamer modification improves the adenoviral transduction of malignant glioma cells.

Retraction notice to: Myosin VI contributes to malignant proliferation of human glioma cells.

Suggest Documents

Improved Adeno-associated Viral Gene Transfer to Murine Glioma.

Light-controlled inhibition of malignant glioma by opsin gene transfer.

Gene therapy for malignant glioma.

Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma.

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line.

Targeted gene transfer to the brain via the delivery of brain-penetrating DNA nanoparticles with focused ultrasound.

Corrigendum to "CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells".

p16 Gene Transfer Induces Centrosome Amplification and Abnormal Nucleation Associated with Survivin Downregulation in Glioma Cells.

The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.

Gene transfer into murine hematopoietic stem cells and bone marrow stromal cells.

Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy.

Bradykinin enhances invasion of malignant glioma into the brain parenchyma by inducing cells to undergo amoeboid migration.

SRL-Coated PAMAM Dendrimer Nano-Carrier for Targeted Gene Delivery to the Glioma Cells and Competitive Inhibition by Lactoferrin.

Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.

Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiency.

Nonhuman adenovirus vectors for gene transfer to the brain (BrainCAV).

Vaccine therapies in malignant glioma.

Malignant glioma in laboratory workers.

Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells.

Serial transfer of a human gene to rodent cells by sequential chromosome-mediated gene transfer.

Immunotherapy for malignant glioma.

BCNU and malignant glioma.

Aptamer modification improves the adenoviral transduction of malignant glioma cells.

Retraction notice to: Myosin VI contributes to malignant proliferation of human glioma cells.

Retrovirus-mediated gene transfer targeted to malignant glioma cells in murine brain.

Recommend Documents

Follow Us